Spero Therapeutics, Inc. (SPRO) Sees Surge in Pre-Market Trading
Spero Therapeutics, Inc. (NASDAQ: SPRO), a pioneering biopharmaceutical company specializing in treatments for bacterial infections and rare diseases, experienced a remarkable pre-market surge on Thursday, following a static day on Wednesday. The stock exhibited a sudden climb of 15%, indicating significant investor interest. This surge appears to be directly linked to the recent earnings release. […]
Spero Therapeutics, Inc. (SPRO) Sees Surge in Pre-Market Trading Read More »